News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

RepRegen™ Ltd. (Formerly Known as BioCeramic Therapeutics) Receives Visit from His Royal Highness, Prince Andrew, Duke of York



3/2/2011 10:34:07 AM

LONDON--(BUSINESS WIRE)--RepRegen, the ‘smart biomaterials’ company, welcomed His Royal Highness, Prince Andrew, Duke of York to its headquarters earlier today, where he met with CEO Mr. Ian Brown and CSO Professor Molly Stevens and learned about RepRegen’s commercialization plans for StronBone in Europe and the U.S.

Read at BioSpace.com

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES